Kenrick Ng, Consultant Medical Oncologist at Barts Experimental Cancer Medicine Centre, shared a post on X:
“My personal take on the 5 practice influencing studies in prostate cancer in ASCO26.
We span the disease spectrum speaking about the landmark PROTEUS and TALAPRO3, but also impactful smaller studies like CHAMP, ARACOG and Decipher ENZAMET.”
Other articles about GU Oncology on OncoDaily.